Delivery Order SPE2DR25D3301-SPE2DR26F20WT
- Not listed
- On January 13, 2026, the Defense Logistics Agency awarded a $4,066.16 delivery order to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of February 4, 2026 and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This non-competitive, firm fixed-price delivery order is scheduled for completion by February 4, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 16, 2026, for the supply of Nemluvio 30 mg pens, with a completion deadline of February 9, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Nemluvio 30 mg pens, with a ceiling value of $1,867.72. This firm fixed-price delivery order is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,787.60 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nemluvio 30 mg pens. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by October 8, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for supply of Nemluvio 30 mg pens, with completion targeted for February 4, 2026. This is a non-set-aside, competitively awarded contract with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a $6,099.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Nemluvio 30 mg pens, with an ultimate completion date of January 30, 2026. This contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $7,471 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for supply of Nemluvio 30 mg pens. The contract is a firm fixed-price, competitive award with no set-aside designation and is scheduled for completion by November 28, 2025. AmerisourceBergen will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Nemluvio 30 mg pens, with an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20WTDelivery Order
On January 16, 2026, the Defense Logistics Agency awarded a $8,132.32 delivery order (Contract No. 4570541335) to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This firm fixed-price delivery order is scheduled for ultimate completion on February 9, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The arrangement enables efficient fulfillment of federal medical supply needs across Department of Defense healthcare systems, military treatment facilities, and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 1/15/26 |